StockWatch
·
Healthcare Research- Analytics & Technology
Board Meeting24 Oct 2026, 11:00 am

Vimta Labs Board Meeting on Oct 30 to Approve Q2 FY27 Results

AI Summary

Vimta Labs Ltd has announced that its Board of Directors will convene on October 30, 2026, to consider and approve the Unaudited Financial Results for the quarter and half-year ended September 30, 2026. The company has also informed about the closure of the trading window from October 1, 2026, until 48 hours after the announcement of the financial results, in compliance with SEBI regulations. The intimation is available on the company's website.

Key Highlights

  • Board meeting scheduled for October 30, 2026.
  • To consider Unaudited Financial Results for Q2 FY27.
  • Trading window closure from October 1, 2026.
  • Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.